Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424834
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-12
Brief Title:
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
A Randomized Controlled Study of Targeted Medical Therapy Versus Placebo for Angina and Non- Obstructive Coronary Arteries The MVP-ANOCA Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MVP-ANOCA
Brief Summary:
The goal of this clinical trial is to learn if targeted medical therapy will improve symptoms and quality of life in patients with angina and non-obstructive coronary arteries compared to placebo after the underlying cause of the chest pain has been ascertained by coronary function testing
Participants will be treated with either medications that target the underlying cause of their chest pain or placebo for 4 weeks after a drug titration phase of 1-3 weeks They will be asked to complete a series of questionnaires to evaluate their quality of life at the beginning and end of the study
Participants will be treated with either medications that target the underlying cause of their chest pain or placebo for 4 weeks after a drug titration phase of 1-3 weeks They will be asked to complete a series of questionnaires to evaluate their quality of life at the beginning and end of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 24POST1189688 | OTHER_GRANT | American Heart Association | None |